Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with

Dexcom highlights breakthrough type 2 diabetes outcomes at ATTD

A man wears the Dexcom G7 on his arm while taking photographs. [Image courtesy of Dexcom]Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026. San Diego-based Dexcom plans to highlight the benefits of its continuous glucose monitor (CGM) biosensor technology for people with all types of diabetes across the 19th annual Advanced Technologies and Treatments for Diabetes Conferen…

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes ...